Hagino T, Uchiyama A, Kosaka K, Araki T, et al. A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naive versus -experienced patients. J Am Acad Dermatol 2025 Sep 15:S0190-9622(25)02822.
PMID: 40962190